Generation Bio Co. (GBIO) SEC Filing 8-K Material Event for the period ending Friday, February 4, 2022

Generation Bio Co.

CIK: 1733294 Ticker: GBIO

View differences made from one to another to evaluate Generation Bio Co.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Generation Bio Co..


Assess how Generation Bio Co.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Generation Bio Co.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: GBIO
CIK: 1733294
Form Type: 8-K Corporate News
Accession Number: 0001558370-22-000983
Submitted to the SEC: Thu Feb 10 2022 7:35:51 AM EST
Accepted by the SEC: Thu Feb 10 2022
Period: Friday, February 4, 2022
Industry: Pharmaceutical Preparations
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: